ABCL AbCellera Biologics Inc.: institutional ownership and insider trading
144 funds reported holding $1.01B of AbCellera Biologics Inc. in their latest 13F filings; in Q2 2026 funds net sold $53.8M, with 38 new positions and 28 funds selling out; over the last 12 months insiders bought $2.68M and sold $0 on the open market; over its last four quarters it reported revenue of $66.2M and net income of −$165M.
ABCL revenue and earnings
- Quarter ended Jun 30, 2026: revenue $4.05M, net income −$55.4M, EPS -0.18
- Quarter ended Mar 31, 2026: revenue $8.32M, net income −$43.2M, EPS -0.14
- Quarter ended Dec 31, 2025: revenue $44.9M, net income −$8.95M, EPS -0.03
- Quarter ended Sep 30, 2025: revenue $8.96M, net income −$57.1M, EPS -0.19
Famous investors holding ABCL
- Two Sigma (Two Sigma Investments): $81.9M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $7.78M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $21.6M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $4.07M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $357K, 0.0% of the portfolio
Largest institutional holders of ABCL
- BAKER BROS. ADVISORS LP — $259M
- TD Waterhouse Canada Inc. — $128M
- Capital World Investors — $107M
- TWO SIGMA INVESTMENTS, LP — $81.9M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $48.2M
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — $33.9M
- ArrowMark Colorado Holdings LLC — $32.2M
- BlackRock, Inc. (BLK) — $29.9M
- SUSQUEHANNA INTERNATIONAL GROUP, LLP — $24.5M
- DRIEHAUS CAPITAL MANAGEMENT LLC — $22.5M
Recent ABCL insider trades
- Aug 24, 2026: Hayden Michael R bought 53,613 shares ($570K)
- Aug 18, 2026: Montalbano John S. bought 10,000 shares ($110K)
- Aug 14, 2026: Booth Andrew bought 37,200 shares ($384K)
- Aug 12, 2026: Hayden Michael R bought 46,387 shares ($481K)
5%+ owners
- Baker Bros. Advisors LP: 10.8% (Schedule 13G/A, filed May 7, 2026)
Who owns the most ABCL stock?
The largest institutional holders of AbCellera Biologics Inc. in the latest 13F filings are BAKER BROS. ADVISORS LP ($259M), TD Waterhouse Canada Inc. ($128M), Capital World Investors ($107M).
Are insiders buying or selling ABCL?
Over the last 12 months insiders bought $2.68M and sold $0 of AbCellera Biologics Inc. stock on the open market (SEC Form 4).
Which famous investors own ABCL?
Two Sigma, Renaissance Technologies, Ken Griffin, Izzy Englander, D. E. Shaw.
What was ABCL's revenue last quarter?
AbCellera Biologics Inc. reported revenue of $4.05M for the quarter ended June 30, 2026, with net income of −$55.4M.
Which ETFs hold ABCL?
4 ETFs and mutual funds hold it among their top 100 positions, including CPAI, IDNA, GWX, BBC.